ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,297.60
0.33%
Dow Jones
38,239.66
0.40%
Brent Oil
87.935
0.29%
Bitcoin
62,431.47
-0.90%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
04/29/20246:45AMGlobeNewswire Inc.Gravitas Worldwide Streamlines Customs Clearance Using Descartes e-Customs™ SolutionNASDAQ:DSGXDescartes Systems Group Inc
04/29/20246:45AMGlobeNewswire Inc.Ocugen Announces OCU400—Modifier Gene Therapy—Phase 1/2 Data Presentation at Retinal Cell and Gene Therapy Innovation Summit 2024NASDAQ:OCGNOcugen Inc
04/29/20246:45AMBusiness WireASA Gold and Precious Metals Fund Adopts Limited-Duration Shareholder Rights PlanNYSE:ASAASA Gold and Precious Metals Limited
04/29/20246:45AMBusiness WireBWXT Named First Member of GE Vernova Nuclear’s Small Modular Reactor Supplier GroupNYSE:BWXTBWX Technologies Inc
04/29/20246:45AMGlobeNewswire Inc.Gravitas Worldwide Streamlines Customs Clearance Using Descartes e-Customs™ SolutionTSX:DSGDescartes Systems Group Inc
04/29/20246:45AMGlobeNewswire Inc.Gravitas Worldwide Streamlines Customs Clearance Using Descartes e-Customs™ SolutionTG:DC2Descartes Sys Grp Inc
04/29/20246:45AMBusiness WirePfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual MeetingNYSE:PFEPfizer Inc
04/29/20246:44AMPR Newswire (Canada)Repreneuriat : 92 % des propriétaires de PME souhaitent que l'entrepreneuriat soit enseigné à l'école
04/29/20246:43AMBusiness WireSpire Global Secures Multi-Million Dollar Deal with Financial Firm for Weather ForecastsNYSE:SPIRSpire Global Inc
04/29/20246:43AMPR Newswire (US)Gstar Announced the Strategic Move: Groundbreaking of Silicon Wafer Factory Construction in Indonesia
04/29/20246:40AMGlobeNewswire Inc.Gildan Activewear Files Proxy Circular and Board of Directors Issues Letter to ShareholdersTSX:GILGildan Activewear Inc
04/29/20246:40AMGlobeNewswire Inc.Gildan Activewear Files Proxy Circular and Board of Directors Issues Letter to ShareholdersNYSE:GILGildan Activewear Inc
04/29/20246:40AMBusiness WireStabilità geopolitica, crescita inclusiva e sicurezza energetica sono al centro del Meeting speciale del World Economic Forum a Riyadh
04/29/20246:35AMGlobeNewswire Inc.Award-Winning Biophilic Artist Susie Frazier to Hold Neuroinclusion Media Event at the WELL Conference on May 7
04/29/20246:33AMPR Newswire (US)Xinhua Silk Road: SE China's Quanzhou seeks win-win for heritage protection, cultural tourism
04/29/20246:33AMPR Newswire (Canada)Xinhua Silk Road: SE China's Quanzhou seeks win-win for heritage protection, cultural tourism
04/29/20246:32AMGlobeNewswire Inc.Reporting of transactions made by members of the Board of Directors or Executive Management or their closely associated persons
04/29/20246:31AMPR Newswire (US)Qudian Files Its Annual Report on Form 20-FNYSE:QDQudian Inc
04/29/20246:30AMBusiness WireHealthTrust Performance Group Celebrates 25 Years of Serving Healthcare
04/29/20246:30AMBusiness WireHenry Schein to Present at Investor Conferences in May 2024NASDAQ:HSICHenry Schein Inc
04/29/20246:30AMGlobeNewswire Inc.Alberta Motor Association Insurance Company Selects IMS for Pay-As-You-Go Program
04/29/20246:30AMGlobeNewswire Inc.Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depressionNASDAQ:CMPSCOMPASS Pathways PLC
04/29/20246:30AMGlobeNewswire Inc.AirBoss Awarded Bandolier Contract Valued at up to US$45 millionTSX:BOSAirBoss of America Corp
04/29/20246:30AMGlobeNewswire Inc.Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depressionTG:5Y6Compass Pathways Plc
04/29/20246:30AMBusiness WireAult Alliance Reports Preliminary Revenue of $36 Million for First Quarter 2024AMEX:AULTAult Alliance Inc
04/29/20246:30AMBusiness WireArizona Sonoran Drills 1,206 ft (368 m) of 0.56% CuT at MainSpring and Completes Initial MainSpring Inferred Drill ProgramTSX:ASCUArizona Sonoran Copper Company Inc
04/29/20246:30AMPR Newswire (US)NexusTek Announces Appointment of Hamilton Yu as New CEO and Bobby Christian as Executive Chairman
04/29/20246:30AMPR Newswire (US)Daqo New Energy Announces Unaudited First Quarter 2024 ResultsNYSE:DQDaqo New Energy Corp New
04/29/20246:30AMPR Newswire (US)An Interactive Musical Celebrating South Bay's Vibrant Community Premieres May 29th - TuYo Theatre Presents "Pásale Pásale"
04/29/20246:30AMPR Newswire (Canada)/R E P R I S E -- Décès de M. Christopher Lavoie et de M. Régis Lavoie - Reprise des audiences le 29 avril 2024/

Your Recent History

USOTC
VXIT
Virexit Technologies (PK)
COIN
SHIBUSD
SHIBA INU
NASDAQ
AMRN
Amarin
USOTC
IFUS
Impact Fusion (PK)
NASDAQ
RVNC
Revance Therapeutics
NASDAQ
COOP
Mr Cooper
COIN
BTCUSD
Bitcoin
USOTC
BIEL
Bioelectronics (PK)
USOTC
CLNV
Clean Vision (QB)
USOTC
GVSI
Good Vibrations Shoes (PK)
USOTC
RDGL
Vivos (QB)
USOTC
TPTW
TPT Global Tech (CE)
USOTC
NSAV
Net Savings Link (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
IPIX
Innovation Pharmaceuticals (CE)
USOTC
SPZI
Spooz (PK)
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved